News - Asia-Pacific, Mylan Laboratories

Filter

Popular Filters

Mylan pushes further into India, introducing critical care segment

Mylan pushes further into India, introducing critical care segment

12-03-2014

US generics major Mylan says its Indian subsidiary has launched a Critical Care segment in India. The…

AmbisomeAntibiotics and Infectious diseasesAsia-PacificGenericsIndiaMarkets & MarketingMylan Laboratories

Roche sues Biocon and Mylan over Herceptin biosimilar; US puts pressure on India over IP

Roche sues Biocon and Mylan over Herceptin biosimilar; US puts pressure on India over IP

10-02-2014

Swiss pharma major Roche’s Indian subsidiary has sued Bangalore-based Biocon and US generics firm Mylan…

Asia-PacificBioconBiosimilarsCanmabHerceptinHertrazIndiaLegalMylan LaboratoriesOncologyPatentsPharmaceuticalRegulationRoche

Mylan debuts Hertraz, first Herceptin biosimilar, in India

Mylan debuts Hertraz, first Herceptin biosimilar, in India

03-02-2014

US generics major Mylan has launched the world's first trastuzumab biosimilar in India. The product,…

Asia-PacificBioconBiosimilarsGenericsHerceptinHertrazIndiaMarkets & MarketingMylan LaboratoriesOncologyRoche

Mylan gets exclusive rights to distribute Gilead branded drugs in India

Mylan gets exclusive rights to distribute Gilead branded drugs in India

31-01-2014

US generics major Mylan says its India-based subsidiary has been named) exclusive branded medicines business…

AmbisomeAnti-viralsAsia-PacificBiotechnologyGilead SciencesIndiaMarkets & MarketingMylan LaboratoriesStribildTruvadaViread

Mylan-Biocon Herceptin biosimilar gets first Indian approval

Mylan-Biocon Herceptin biosimilar gets first Indian approval

26-11-2013

US generic major Mylan says that its partner, India-based biotechnology firm Biocon has received approval…

Asia-PacificBioconBiosimilarsGenericsHerceptinHertrazMylan LaboratoriesOncologyRegulationRoche

Mylan's deal to acquire Strides Arcolab's unit looks set to proceed

22-08-2013

US generics and specialty drugmaker Mylan (NYSE: MYL) $1.6-billion foreign direct investment proposal…

Agila SpecialitesAsia-PacificGenericsMergers & AcquisitionsMylan LaboratoriesRegulationStrides Arcolab

Mylan delivers "one pill once a day" ARV in South Africa; Cipla Debuts first Enbrel biosimilar

17-04-2013

USA-based generic drugmaker Mylan (Nasdaq: MYL) says that it has delivered, through its South African-based…

AmgenAnti-Arthritics/RheumaticsAnti-viralsAsia-PacificBiotechnologyCiplaEnbrelEtaceptGenericsMarkets & MarketingMylan LaboratoriesPfizerRest of the World

Mylan buys Indian production unit from SMS Pharma for $33 million

18-10-2012

Following speculation that started last month, India's SMS Pharmaceuticals this week confirmed that it…

Asia-PacificGenericsMergers & AcquisitionsMylan LaboratoriesProductionSMS Pharmaceuticals

Mylan chosen to supply ARVs to India's national AIDS control body

04-09-2012

Leading USA-based generic drugmaker Mylan (Nasdaq: MYL) says that its India-based subsidiary Mylan Laboratories…

Anti-viralsAsia-PacificGenericsMarkets & MarketingMylan Laboratories

Pfizer teams up with Mylan to drive generics business in Japan

23-08-2012

Global pharma behemoth Pfizer (NYSE: OFE) and generics drug major Mylan (Nasdaq: MYL) have signed a definitive…

Asia-PacificGenericsMarkets & MarketingMylan LaboratoriesPfizerProduction

Mylan starts operating in India, with portfolio of ARVs

07-08-2012

US generics and specialty drugmaker Mylan (Nasdaq: MYL) says that its India based subsidiary, Mylan Pharmaceuticals…

Anti-viralsAsia-PacificGenericsMarkets & MarketingMylan Laboratories

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top